首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones
【24h】

Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones

机译:聚ADP核糖聚合酶激活核蛋白酶体以降解氧化损伤的组蛋白

获取原文
获取原文并翻译 | 示例
       

摘要

The 20S proteasome has heen shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to axidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemo- therapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemo- therapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases signifi- cantly within minutes. Both increased proteolytic susceptibil- ity of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid up- regulation of 205 proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, ~(14)C-ADP ribose incorpora- tion assays, immunoblotting, in vitro reconstitution experi- ments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antihodies. The poly- ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more effi- ciently and therefore is
机译:已经表明20S蛋白酶体在细胞质中对氧化修饰的蛋白质的降解起主要作用。核蛋白也容易被氧化,哺乳动物细胞核中含有蛋白酶体。在人类中,由于抗肿瘤化学疗法,肿瘤细胞经常受到氧化,并且K562人类骨髓性白血病细胞比非恶性细胞具有更高的核蛋白酶体活性。适应氧化应激似乎是对许多化学治疗药物产生长期耐药性的因素之一,而诱导性肿瘤对氧化的耐药性机制非常重要。过氧化氢处理K562细胞后,模型蛋白酶体肽底物suc-LLVY-MCA的降解和细胞核中氧化组蛋白的降解在数分钟内显着增加。组蛋白底物的蛋白水解敏感性增加(由氧化修饰引起)和蛋白酶体酶复合物的活化在氧化应激期间独立发生。如抑制剂实验,〜(14)C-ADP核糖结合试验,免疫印迹,体外重构实验所示,这种205个蛋白酶体活性的快速上调伴随并取决于蛋白酶体的聚ADP核糖基化。 -用抗聚-ADP核糖聚合酶抗体对(活化的)蛋白酶体进行免疫沉淀和免疫沉淀。聚ADP核糖基化介导的活化核20S蛋白酶体能够更有效地去除氧化损伤的组蛋白,因此是

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号